MALDI-TOF mass spectrometry-based quantification of C-peptide in diabetes patients.
MeiHua WanYichao WangLingpeng ZhanJia FanTony Y HuPublished in: European journal of mass spectrometry (Chichester, England) (2019)
A simple, high-throughput, cost effective and quantitative MALDI-TOF MS C-peptide assay has been successfully developed and validated in clinical serum samples.
Keyphrases
- mass spectrometry
- high throughput
- liquid chromatography
- end stage renal disease
- high resolution
- gas chromatography
- capillary electrophoresis
- newly diagnosed
- ejection fraction
- high performance liquid chromatography
- chronic kidney disease
- type diabetes
- cardiovascular disease
- prognostic factors
- single cell
- ms ms
- metabolic syndrome
- patient reported outcomes